Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

The Covaxin contract to Brazil landed in controversy after the South American countrys Attorney General reportedly launched a probe into the deal.

Hyderabad: The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotech’s COVID-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal.

“By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract.
According to CGU’s preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis,” Brazil Health Minister Marcelo Queiroga tweeted.

---

The Covaxin contract to Brazil landed in controversy after the South American country’s Attorney General reportedly launched a probe into the deal.

“It is noteworthy that the @govbr did not pay ANY CENT for the Covaxin vaccine.

The measure does not compromise the pace of the vaccination campaign against #Covid19 in Brazil, since there is no approval from Anvisa for emergency or definitive use of the immunizing agent,” Queiroga said in another tweet.

---

Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .